The evaluation of gastric inhibitory polypeptide (GIP) as the enterogastrone.
D000818:Animals; D001786:Blood Glucose; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood / Q000494:pharmacology*; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D006943:Hyperglycemia / Q000503:physiopathology; D006949:Hyperlipidemias / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D010418:Pentagastrin / Q000494:pharmacology
D001786:Blood Glucose; D005768:Gastrointestinal Hormones; D007328:Insulin; D005749:Gastric Inhibitory Polypeptide; D010418:Pentagastrin